SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-24-016162
Filing Date
2024-05-13
Accepted
2024-05-13 10:53:22
Documents
16
Period of Report
2024-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A mbrx20240513_8ka.htm   iXBRL 8-K/A 26783
2 EXHIBIT 99.1 ex_672442.htm EX-99.1 108592
7 logo.jpg GRAPHIC 5546
  Complete submission text file 0001437749-24-016162.txt   297500

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20240513.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20240513_def.xml EX-101.DEF 11792
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20240513_lab.xml EX-101.LAB 15821
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20240513_pre.xml EX-101.PRE 12007
19 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20240513_8ka_htm.xml XML 3002
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37758 | Film No.: 24937498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)